	El Costo De Ventas		Fecha
AbbVie	USD 4.55B	757M	2025-12
Acadia Pharmaceuticals	USD 26.22M	4.58M	2025-12
Agios Pharmaceuticals	USD 1.88M	199K	2025-12
ALKERMES	USD 46.21M	5.38M	2025-12
Alnylam Pharmaceuticals	USD 267.72M	67.57M	2025-12
Amgen	USD 1.79B	128M	2025-12
Biogen	USD 810.1M	205.1M	2025-09
BioMarin Pharmaceutical	USD 161.56M	16.62M	2025-12
Cytokinetics	USD 99.23M	13.32M	2025-09
Exelixis	USD 26.48M	7.91M	2025-12
Gilead Sciences	USD 1.62B	50M	2025-12
Halozyme Therapeutics	USD 102.15M	29.14M	2025-12
Incyte	USD 121.18M	22.18M	2025-12
Ionis Pharmaceuticals	USD 8M	5.66M	2025-12
Nektar Therapeutics	USD 4.43M	5.3M	2024-09
Neurocrine Biosciences	USD 17.6M	246.4M	2025-12
Pfizer	USD 6.29B	2.12B	2025-12
Prothena	USD 28.94M	11.58M	2025-09
Regeneron Pharmaceuticals	USD 584.6M	63M	2025-12
Repligen	USD 94.08M	5.79M	2025-12
Rigel Pharmaceuticals	USD 8.03M	5.22M	2024-09
Sarepta Therapeutics	USD 399.38M	247.93M	2025-12
Teva Pharmaceutical Industries	USD 2.06B	120M	2025-12
Ultragenyx Pharmaceutical	USD 29M	1.01M	2025-12
Vertex Pharmaceuticals	USD 466M	51.2M	2025-12
Xoma	116K	112.7K	2024-06

Neurocrine Biosciences El Costo De Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.